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Introduction: Numerous observations indicate that rheumatoid arthritis (RA) has a bone marrow component. In
parallel, local synovial changes depend on neuronal components of the peripheral sympathetic nervous system.
Here, we wanted to analyze whether collagen II-induced arthritis (CIA) has an impact on number, adhesion,
apoptosis, and proliferation of the macrophage subset of bone marrow cells and how alterations in neurotransmitter
microenvironment affect these properties.
Methods: Bone marrow-derived macrophages (BMMs) were isolated from Dark Agouti rats at different stages of CIA,
and number, adhesion, caspase 3/7 activity, and proliferation were analyzed in the presence of acetylcholine (ACh),
noradrenaline (NA), and vasoactive intestinal peptide (VIP).
Results: Opposed to enhanced CD11b+ (cluster of differentiation 11b-positive) and EMR1+ (epidermal growth
factor-like module-containing mucin-like hormone receptor-like 1-positive) cells, characterizing the macrophage subset,
in native bone marrow of rats with acute inflammatory arthritis, we found decreased numbers of CIA macrophages
after enrichment and culture in comparison with healthy (control) animals. Adhesion studies revealed significantly
reduced attachment to plastic in acute arthritis and collagen type I and fibronectin in chronic arthritis. Additionally, we
found a strong reduction in proliferation of BMMs at CIA onset and in the chronic phase of CIA. Apoptosis remained
unaffected. Neurotransmitter stimulation profoundly affected proliferation, adhesion, and apoptosis of BMMs from
CIA and control rats, depending on disease time point. Cultured BMMs from CIA and control animals expressed
neurotransmitter receptors for ACh, VIP and NA, but the expression profile seemed not to be affected by CIA.
Conclusions: Induction of CIA distinctly inhibits proliferation of BMMs in low- and non-inflammatory phases and
reduces attachment to plastic at the acute inflammatory arthritis stage and adhesion to collagen I and fibronectin at
the chronic stage. Influence of neurotransmitter stimulation on adhesion, apoptosis, and proliferation is altered by CIA
depending on disease stage. We suggest an altered reactivity of BMMs to neurotransmitter stimulation caused by CIA
and maybe also by aging.Introduction
Rheumatoid arthritis (RA) is a systemic autoimmune
disorder that is characterized by massive inflammation
and destruction of cartilage and bone adjacent to the af-
fected joints. Locally, activated macrophage/monocytes
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creativecommons.org/publicdomain/zero/1.0/tumor necrosis factor (TNF), interleukin-1beta (IL-1β),
IL-6, and chemotactic factors like macrophage inflam-
matory protein-1beta (MIP-1β) and monocyte chemo-
attractant protein-1 (MCP-1), leading to enhanced
infiltration of immune cells into the inflamed joint [1, 2].
Owing to pro-osteoclastogenic properties of TNF and
IL-1, the microenvironment in inflamed joints provides
the prerequisites for a self-fueling, vicious cycle of in-
flammation and bone destruction induced by macro-
phage infiltration [3].
The source of macrophage precursors is contained in
the hematopoietic stem cell (HSC) niche within the bonearticle distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
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also a bone marrow disorder [4] (e.g., formation of bone
marrow edema [5], a shift in HSC progenitors toward
myeloid cells [6], enhanced immuno-senescence of
hematopoietic progenitor cells [7], and case-dependent
treatment or disease amelioration of RA by bone marrow
transplantation (reviewed in [8])).
During RA, changes in local synovial innervation occur
and this alters the neurotransmitter composition and may
provide a novel regulatory environment for blood- and
bone marrow-derived macrophage progenitor cells. Dur-
ing inflammation, anti- and pro-inflammatory functions of
the sympathetic nervous system have been described [9].
RA-associated alterations in synovial innervation include
the decreased detection of tyrosine hydroxylase (TH)-
positive nerve fibers in synovial membrane regions and
the appearance of TH-positive cells providing a decentra-
lized source for noradrenaline (NA) [10, 11]. Aside from
catecholaminergic signaling, cholinergic signaling is asso-
ciated mostly with anti-inflammatory effects mediated via
the α7 subunit of the nicotinic acetylcholine (ACh) receptor
[12]. Cells expressing the α7 ACh receptor were detected in
the synovial lining layer of patients with RA and psoriatic
arthritis and to a lesser extent in healthy controls [13].
This study intended to analyze whether changes in the
local neurotransmitter microenvironment in arthritis affect
bone marrow-derived macrophages (BMMs), as inflamma-
tory lesions can penetrate deep into the bone marrow [5].
Immune cells express a variety of neurotransmitter re-
ceptors and hence allow extensive modulation by nervous
firing [14]. Therefore, we examined whether metabolic
properties like number, proliferation, apoptosis, and adhe-
sion of BMMs change in the time course of a collagen II-
induced arthritis (CIA) rat model and whether stimulation
of cultured BMMs with neurotransmitters NA, ACh, and
vasoactive intestinal peptide (VIP) further modulates cell
metabolism in vitro. The study provides novel information
on how progression of CIA alters autonomous macrophage
properties and how catecholaminergic and cholinergic/pep-
tidergic neurotransmitters participate in these alterations.
Methods
Animals
Female Dark Agouti rats were purchased from Janvier
Labs (Le Genest St. Isle, France) at the age of 9 weeks.
Animals were housed at four or six animals per cage and
were allowed to adapt to animal laboratory conditions for
1 week. Rats were fed standard laboratory chow and water
ad libitum and were kept under standard housing condi-
tions in a 12 h light-dark cycle.
Collagen II-induced arthritis model
All animal experiments were approved by and conducted
according to institutional and governmental regulationsfor experimental animal usage (Ethical Review Committee,
Government of the Oberpfalz Az. 54–2532.1-25/13). For
arthritis induction, rats were anaesthetized and 300 μg dis-
solved bovine collagen II (#804001-sol; MD Bioproducts,
Egg, Switzerland) emulsified in an equal volume of in-
complete Freund adjuvant (Sigma-Aldrich, Taufkirchen,
Germany) was intracutaneously injected at the base of the
tail. Controls received equal volume of 0.9 % sodium chlor-
ide (NaCl) solution (Braun Melsungen AG, Melsungen,
Germany). Development of arthritis was monitored by
determination of body weight and arthritis score at the
respective sampling days. For scoring, each paw was
evaluated separately. Three regions were analyzed and one
point assigned for signs of inflammation (redness, swell-
ing) occurring in toes/fingers, metatarsus/metacarpus, or
ankle. An additional point was given if normal use of the
hind limbs was impaired. For front paws, only fingers and
metacarpus were evaluated. Altogether, a maximum of 12
points per animal could be assigned (adapted from [9]).
Isolation of bone marrow macrophages and primary
culture
The isolation protocol for rat bone marrow from Ahmed
et al. [15] was modified. Shortly, rats were killed 10, 15,
20, and 40 days post-immunization (p. i.) with carbon
dioxide (CO2), and femur and tibia were collected aseptic-
ally. Bones were cut in half and placed in a 1.5 ml reaction
tube. Bone marrow was collected by centrifugation
(5 min, 5000 × g), cells were separated with a 40 μm cell
strainer, and erythrocytes were lysed via hypotonic shock
in sterile distilled water. For analysis of surface markers
CD11b (cluster of differentiation 11b) and EMR1 (epider-
mal growth factor-like module-containing mucin-like hor-
mone receptor-like 1), native bone marrow cells were
collected before erythrocyte lysis. To analyse adhesion,
apoptosis, and proliferation, we used an established proto-
col to enrich BMMs from whole bone marrow by their
ability to attach to untreated plastic [16]. Separation via
plastic adhesion provides easy and reliable access to the
macrophage proportion of bone marrow cells, and the ob-
tained population is further considered to be BMMs. After
centrifugation (5 min, 245 × g), remaining bone marrow
cells were suspended in 20 ml of macrophage medium
consisting of alpha-minimum essential medium (α-MEM)
with 10 % fetal calf serum (FCS), 2 % glutamate and 1 %
antibiotics/antimycotics (Sigma-Aldrich) and 20 ng/ml
recombinant rat macrophage colony-stimulating factor
(M-CSF) (#400-28; Peprotech, Rocky Hill, NJ, USA). Five
milliliters of the suspension was placed in a 100 × 20 mm
bacterial petri dish (#430591; Corning, Corning, NY, USA)
and cultivated at 37 °C and 5 % CO2. After 2 days of pre-
culture, plates were washed with phosphate-buffered sa-
line (PBS), and all non-adherent cells in the supernatant
were removed. Attached cells, regarded as macrophages,
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acid (EDTA) in PBS (Sigma-Aldrich), a 5 min incubation
period on ice followed by 1 min at −20 °C and a cell scraper.
After centrifugation and resuspension in α-MEM, the cell
number was determined with a Cedex automated cell coun-
ter (Roche Diagnostics GmbH, Mannheim, Germany), and
macrophages were seeded at a density of 1.5 × 104 cells/cm2
for indicated experiments. Macrophages cultivated in
macrophage medium without neurotransmitters are further
referred to as non-stimulated cells. Acetylcholine chloride
(#A22661), rat/human/porcine vasoactive intestinal peptide
(#V6130), and L-(−)-norepinephrine (+)-bitartrate salt
monohydrate (#N5785), used for the stimulation experi-
ments, were purchased from Sigma-Aldrich.
Immunofluorescence staining of neurotransmitter
receptors
In total, 10,000 macrophages were seeded into the cavity of
an eight-well chamber slide (BD Biosciences, Heidelberg,
Germany) and cultured in macrophage medium contain-
ing 50 ng/ml recombinant rat soluble receptor activator of
NFκB ligand (RANKL) (#400-30; Peprotech) for 5 days
with one change of medium after 3 days of culture. After
5 days, cell population (macrophages and osteoclasts) was
fixed in 4 % paraformaldehyde for 10 min and washed
with PBS. Until staining procedure, cells were stored at
4 °C. Unspecific staining was blocked with 5 % normal
goat serum (NGS) (Sigma-Aldrich) in PBS for 20 min at
room temperature (RT). Neurotransmitter receptors were
detected by using rabbit polyclonal immunoglobuline
(Ig) G against rat pituitary adenylate cyclase-activating
peptide (PACAP) receptor 1 (1:50, sc-30018, Santa Cruz
Biotechnologies, Dallas, TX, USA) and rabbit polyclonal
antibody against muscarinic ACh receptor M5 (1:400,
ab41171) and rabbit polyclonal antibody against adrenocep-
tor (AR) β2 (3 μg/ml, ab36956; both Abcam, Cambridge,
UK) as well as rabbit polyclonal antibodies against extra-
cellular sections of ARs α1D (1:100, #AAR-019) and α2B
(1:100, #AAR-021; Alomone Labs, Jerusalem, Israel).
Antibodies were diluted in 1 % NGS/PBS and incubated
overnight at 4 °C. After washing, primary antibodies were
detected with F(ab′)2 fragment of goat anti-rabbit IgG
coupled to Alexa488 (#A11070; Molecular Probes/Life
Technologies, Eugene, OR, USA) diluted in 1 % NGS
in PBS for 1 h at RT. Nuclei were counterstained with
4′,6-diamidino-2-phenylindole (DAPI), and cells were
covered with Fluorescence Mounting Medium from Dako
(Hamburg, Germany). Control staining using only the
secondary antibody F(ab′)2-fragment revealed no unspe-
cific immunofluorescence. Pre-blocking of the antibodies
directed against α1D and α2B ARs with the respective
blocking peptide provided by the manufacturer prevented
staining and confirmed specificity of the antibody (data
not shown).Endpoint polymerase chain reaction for neurotransmitter
receptors
Total RNA was isolated from macrophages by using the
Ambion RNAqueous® Micro total RNA isolation kit (Life
Technologies, Carlsbad, CA, USA) in accordance with
the instructions of the manufacturer. RNA was reverse-
transcribed into complementary deoxyribonucleic acid
(cDNA) by using an Affinity Script QPCR cDNA synthesis
kit (Agilent Technologies, Santa Clara, CA, USA), and
endpoint polymerase chain reaction (PCR) was performed
with JumpStart Taq DNA Polymerase (Sigma-Aldrich)
and primers for neurotransmitter receptors listed in
Additional file 1: Table S1.
Crystal violet adhesion assay
In total, 5000 macrophages per well were seeded in a
96-well plate and were cultured in macrophage medium
without or with 10−6 M ACh, 10−6 M (β2-agonistic), and
10−8 M (α1/2-agonistic) NA or 10−9 M VIP (final con-
centration) for 36 h with no replenishment of neuro-
transmitter during incubation time. Corning Biocoat™
96-well plates pre-coated with collagen type I (#354407),
fibronectin (#354409), and laminin (#354410) were used
for adhesion studies on extracellular matrix (ECM) com-
ponents (Corning). Non-adherent cells were removed by
washing the plates with PBS. Adherent cells were fixed
with 1 % glutaraldehyde solution for 30 min and washed
with PBS. Fixed cells were stained with 0.02 % crystal
violet solution for 15 min at RT and afterwards washed
with tap water. The amount of incorporated cristal violet
dye is considered to be proportional to the number of
cells attached in each well. Incubation in 70 % ethanol
for 3 h on a vertical shaker (100 revolutions per minute)
dissolved crystal violet out of the cells. Absorbance of
ethanol-dissolved crystal violet dye was measured by using
a microplate reader (Tecan Group AG, Männedorf,
Switzerland) at 600 nm. Differences in absorbance values
were correlated with differences in adhesion capacity
of cells.
Caspase 3/7 apoptosis assay
In total, 5000 macrophages per well were seeded in a
black 96-well plate with a clear bottom (BD Biosciences,
Heidelberg, Germany) and allowed to recover overnight in
macrophage medium without neurotransmitters. Cells
were synchronized by serum and M-CSF depletion for
24 h. Apoptosis was analyzed by using the APO-ONE
Homogenous Caspase 3/7 Assay from Promega (Madison,
WI, USA) in accordance with the instructions of the
manufacturer. Briefly, serum-free medium was replaced
by macrophage medium without or with 10−6 M ACh,
10−6 M/10−8 M NA, or 10−9 M VIP (final concentration).
Simultaneously, equal volume of caspase 3/7 assay reagent
was added and the mixture was incubated for 6–10 h
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active caspase 3/7 is present in the cells, the more fluo-
rescent dye is cleaved from the non-fluorescent substrate
(Z-DEVD-R110) and differences in emission of varying
culture conditions can be measured at 521 nm in a fluor-
escence plate reader (Tecan Group AG). This information
is correlated with apoptotic activity.BrdU proliferation assay
With the BrdU (5-bromo-2′-deoxyuridine, thymidine ana-
log) cell proliferation enzyme-linked immunosorbent assay
(ELISA) from Roche Diagnostics GmbH (Mannheim,
Germany), macrophage proliferation was determined in
the presence of ACh, NA, and VIP. Upon addition to cell
culture medium, BrdU is constantly incorporated into
newly synthesized DNA for a defined period of time.
The incorporated amount of BrdU is proportional to the
amount of synthesized DNA and allows the comparison of
proliferative activity between different conditions after de-
tection with a specific BrdU antibody and colorimetric
visualization. For analysis, a total of 5000 macrophages per
well were seeded in a 96-well plate and were allowed to
recover from seeding procedure overnight. After synchro-
nization by serum and M-CSF depletion for 24 h, cells
were cultured 48 h in macrophage medium with BrdU
labeling solution without or with 10−6 M ACh, 10−6 M and
10−8 M NA or 10−9 M VIP (final concentration) with no
replenishment of neurotransmitters during incubation
time. After 48 h, cells were processed in accordance with
the manufacturer’s instructions, including the use of stop
solution, and absorption was measured at 450 nm (refer-
ence wavelength of 690 nm) by using a plate reader (Tecan
Group AG).Flow cytometry
Cell cycle analysis
For this analysis, 1.5–2 × 106 macrophages were seeded
in a petri dish. After recovery from seeding procedure
overnight, macrophages were synchronized by serum
and M-CSF deprivation for 48 h to obtain cells synchro-
nized in G0/G1. Subsequently, cell cycle entry was en-
abled by the addition of FCS and 20 ng/ml M-CSF, and
samples were taken 48 h afterwards. Cell pellets were
washed with cold 2 % bovine serum albumin in PBS and
fixed in methanol-acetone mixture. Quantitative staining
of DNA content with propidium iodide (50 μg/ml for
1 × 106 cells in 500 μl) was performed after RNAse
(1 mg/ml; both Sigma-Aldrich) treatment for 1 h at 37 °C.
DNA content was analyzed in FACS Calibur (Becton
Dickinson, Franklin Lakes, NJ, USA), and data analysis
was performed by using the cell cycle tool of FlowJo
software (Tree Star, now part of FlowJo, LLC, Ashland,
OR, USA).Surface marker and integrin expression analysis
Unspecific staining was blocked with 5 % mouse serum
in PBS for 30 min at 4 °C. Native bone marrow cells and
cultured BMMs were additionally incubated with 1 μl/
1 × 106 cells of purified mouse anti-rat CD32 for 5 min
prior to antibody addition to block Fc-mediated adhesion
of antibodies to rat FcγIII receptors highly expressed by
macrophages (“rat Fc-Block”, #550270; Becton Dickinson).
Afterwards, cultured macrophages and native bone mar-
row cells were stained with antibodies against mouse
anti-rat CD11b (phycoerythrin (PE)-coupled, #562105;
Becton Dickinson) and uncoupled mouse anti-rat EMR1
(#T-3005; BMA Biomedicals, Augst, Switzerland). Unspe-
cific IgA-PE (#562141) and uncoupled mouse IgG1
(#554121; all Becton Dickinson) were used as isotype con-
trols. After washing, uncoupled antibodies were stained
with goat anti-mouse F(ab′)2 fragment Alexa 488-coupled
(Life Technologies, Carlsbad, CA, USA, #A-11017) for
30 min at 4 °C.
Integrin expression of cultured BMMs was analyzed
by using the following antibodies: Armenian hamster
anti-rat CD29 (integrin β1, non-specific for activation
status, PE-coupled, #562154; Becton Dickinson) and
polyclonal rabbit anti-rat CD51/CD61 (integrin ανβ3,
uncoupled, ABIN674784; antibodies-online GmbH, Aachen,
Germany). Unspecific Armenian hamster IgM (PE-coupled,
#562114; Becton Dickinson) and polyclonal rabbit IgG
(uncoupled, ab171870; Abcam) were used as isotype con-
trols. After washing, uncoupled primary antibodies were
detected with goat anti-rabbit F(ab′)2 fragment Alexa
488-coupled (Life Technologies, #A-11070) for 30 min
at 4 °C.
Stained cells were washed with PBS and suspended in
500 μl of PBS for analysis. Fluorescence was measured
with a FACS Calibur (Becton Dickinson). BMM surface
marker expression data were analyzed by using FlowJo
software (Tree Star). Data for surface marker expression
of native bone marrow cells and integrin expression of
cultured BMMs were analyzed by using free Software
Flowing 2.5.1 (developer Perttu Terho, Turku Centre for
Biotechnology, Turku, Finland).
Statistical analysis
Statistical analysis was performed by using Prism 4 from
GraphPad Software (San Diego, CA, USA). Data are dis-
played as mean ± standard error of the mean (SEM) or box-
plot showing box with median and interquartile range and
whiskers from minimum to maximum. Non-parametric
Wilcoxon signed rank test for paired observations (neuro-
transmitter stimulation) was used to test whether individual
values were significantly different to control conditions set
to 100 %. Variations between effects in controls and CIA
groups at the respective time points were compared by
using the two-tailed non-parametric Mann-Whitney test.
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Assessment of experimental arthritis progression and
influence on numbers of bone marrow macrophages
To assess induction of experimental arthritis, body
weight and arthritis score of immunized (CIA) and con-
trol animals (NaCl) were monitored at indicated arthritis
time points which represent the course of the disease:
10 days p. i. represents the non-symptomatic phase,
15 days p. i. represents the onset of arthritis with swelling
and erythema in single finger joints, 20 days p. i. represents
the acute phase of CIA with maximal inflammation in all
four extremities, and 40 days p. i. comprises the chronic
state with no obvious inflammation but massive destruc-
tion of the affected joints (Additional file 2: Figure S1A, B).
Rats immunized with collagen II rapidly lost weight
from day 10 p. i., resulting in a maximum weight differ-
ence of approximately 20 % compared with controls at
day 20 (Additional file 2: Figure S1A). In parallel, the ex-
perimental arthritis score rose from approximately 5
points at day 15 to 11.6 points at day 20 and reached a
maximum of 12 points until day 40. In contrast, control
animals showed no signs of inflammation (Additional
file 2: Figure S1B).
The total number of isolated BMMs, enriched from
bone marrow after 2 days of pre-culture on plastic, was
significantly lower in arthritic animals in comparison with
controls at 20 days p. i. (Fig. 1a). To analyze whether a de-
fect in the macrophage population of the bone marrow is
responsible for this observation, we analyzed native bone
marrow cells as well as the cultured enriched BMM popu-
lation by flow cytometry for markers CD11b (which is
expressed on monocytes, granulocytes, and macrophages)
and EMR1 (a pan-macrophage marker). Twenty days p. i.,
corresponding native bone marrow cells from arthritic
rats showed a significantly higher percentage of cells posi-
tive for macrophage markers CD11b and EMR1 in rela-
tion to bone marrow from healthy controls (Fig. 1b).
However, we did not detect differences in numbers of
CD11b- and EMR1-positive cells between arthritic and
control animals in cultured BMMs but did confirm a
highly enriched BMM population (up to 90 %) for subse-
quent analyses (Fig. 1c).
Macrophages express receptors for acetylcholine,
noradrenaline, and vasoactive intestinal peptide
To assess whether the neurotransmitter reactivity of BMMs
is altered during the time course of CIA, we analyzed ex-
pression of receptors for ACh, NA, and VIP. We detected
mRNA expression of various neurotransmitter receptors
(Additional file 3: Figure S2) and decided to further analyze
protein expression of ARs α1D, α2B, and β2, PACAP recep-
tor 1 (an alternative VIP receptor), and muscarinic ACh re-
ceptor M5 (Fig. 2). Receptors for immunostaining were
selected upon searching the current literature for referencesindicating if any of the receptor subtypes showed altered
expression or effector functions in physiological and patho-
physiological conditions. Alpha2-ARs play a role in regula-
tion of TNF release from macrophages and can be switched
from pro-inflammatory TNF release in healthy conditions to
inhibition of TNF release in a chronic constriction injury rat
model [17]. This switch would be of interest, as blockade of
TNF with therapeutic antibodies seems to play a pivotal role
in restoring defective macrophage apoptosis observed in RA
[18] or, as presented in a conflicting study, in inhibiting cell
migration into inflamed synovial regions of RA patients
[19]. Alpha1D-AR mRNA was detected in peripheral blood
monocytes from patients with juvenile RA but not in per-
ipheral blood mononuclear cells (PBMCs) of healthy donors
[20], indicating a regulatory role for this receptor subtype
under inflammatory conditions. For β2-AR, alterations in
the sympathetic-to-immune cell signaling during adjuvant-
induced arthritis, including immune organ-dependent
changes in β2-AR expression, intracellular signaling, and re-
ceptor phosphorylation, have been described [21]. Protein
analysis of PACAP receptor 1 was included because of its
described anti-inflammatory actions representing a promis-
ing target for an anti-inflammatory therapy [22]. We de-
tected mRNA for M1, M3, and M5 muscarinic ACh
receptors and decided to include only M5 for immunostain-
ing. M3 and M5, but not M1, mRNAs were expressed by
PBMCs described by Costa et al. [23]. The rare subtype M5
showed opposite effects in two different studies, making it
of specific interest in our study: transfected NIH3T3 cells
showed a pro-proliferative response upon M5 receptor
agonism [24], whereas a human melanoma cell line, A2058,
displayed reduced clonogenic potential using a novel signal-
ing pathway via M5 receptor stimulation [25].
Immunostaining of neurotransmitter receptors appears
to be comparable in both BMMs from control and CIA
rats, and there appears to be no obvious change related
to arthritis progression (20 days Fig. 2a, 40 days Fig. 2b).
However, we only qualitatively assessed the staining pro-
file without further quantification.Collagen II-induced arthritis reduced macrophage
adhesion in acute disease state
To address the conflicting observations of significantly
higher numbers of native monocytes/macrophages in the
bone marrow of arthritic animals 20 days p. i. and the cor-
responding significantly lower number of BMMs harvested
after 2 days of pre-culture, we first compared adhesion cap-
acity of cultured BMMs from control and arthritic animals
to plastic surfaces (Fig. 3, more detailed data for adhesion
are listed in Additional file 4: Table S2A-D). Affirmatively,
we detected a significant reduction of adhesion of about
50 % in CIA macrophages compared with control macro-
phages at day 20 (Fig. 3a).
Fig. 1 Number of BMMs and analysis of surface marker expression by flow cytometry. a Total number of BMMs from control and arthritic rats
was determined after 2 days of pre-culture with M-CSF. **P < 0.01. N (control/CIA) = day 10 (9/10), day 15 (10/9), day 20 (10/9), and day 40 (10/9).
b Native bone marrow cells of control and arthritic rats harvested at the acute disease state (20 days) were characterized by flow cytometry for
macrophage-associated markers CD11b and EMR1. *P < 0.05, **P < 0.01. N = 6 for control and CIA. c BMMs of control and arthritic animals were
harvested after 2 days of pre-culture with M-CSF and characterized by flow cytometry for macrophage-associated surface marker expression of
CD11b and EMR1. CD11b: N = 7, EMR1: N = 8 for control and CIA BMMs (sum-up of experimental time points, each N comprises pooled BMMs
from 1–3 animals that were either control or CIA). Boxplots show box with median and interquartile range and whiskers from minimum to
maximum. BMM bone marrow-derived macrophage, CD11b cluster of differentiation 11b, CIA collagen II-induced arthritis, EMR1 epidermal growth
factor-like module-containing mucine-like hormone receptor-like 1, M-CSF macrophage colony-stimulating factor
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has effects on plastic adhesion, we defined the non-
stimulated cultures of control and CIA BMMs as 100 %
(Fig. 3b and c, dotted line). The neurotransmitter effects
on BMMs from control and CIA animals are shown as
percentage of the respective non-stimulated culture.
Stimulation with either 10−6 M ACh or 10−9 M VIP
had no significant impact on adhesion of macrophages
from control animals (Fig. 3b). On the other hand, inmacrophages from arthritic animals, ACh significantly
inhibited adhesion on day 15 p. i. compared with non-
stimulated CIA BMMs (Fig. 3b). VIP increased adhesion of
CIA macrophages on day 20 and 40 p. i. when compared
with non-stimulated macrophages (Fig. 3b).
NA (10−6 M) (signaling via β-AR) reduced adhesion
10 days p. i. of BMMs from control animals compared
with non-stimulated cells. α-AR effects induced by 10−8 M
NA increased adhesion on day 40 in control macrophages
Fig. 2 Neurotransmitter receptor profile during course of CIA. Adrenergic receptors alpha 1D, alpha 2B, and beta 2 and muscarinic ACh receptor M5
and the alternative VIP receptor PACAP receptor 1 were stained in BMMs from control and CIA animals 20 (a) and 40 (b) days post immunization.
Paraformaldehyde-fixed cells were stained after 5 days of differentiation in the presence of M-CSF and RANKL, and sections containing only BMMs were
photographed. Nuclei were counterstained with DAPI. N = 4 (control and CIA). Magnification 200×. ACh acetylcholine, AChR acetylcholine receptor,
BMM bone marrow-derived macrophage, CIA collagen II-induced arthritis, DAPI 4′,6-diamidino-2-phenylindole, M-CSF macrophage colony-stimulating
factor, NA noradrenaline, PACAP pituitary adenylate cyclase-activating peptide, RANKL receptor activator of nuclear factor-kappa-B ligand, VIP vasoactive
intestinal peptide
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CIA macrophages but did not reach significance due to
higher data variance (Fig. 3c).
To determine whether the observed plastic adhesion
defect of BMMs from arthritic animals is an artificial
in vitro cell culture material effect or whether adhesion
to ECM compounds is also affected, adhesion to colla-
gen type I, fibronectin, and laminin was analyzed in ana-
logy to tissue culture plastic (Fig. 4). Of all molecules
analyzed, adhesion to collagen type I and fibronectin
was most noticeably affected, and there was an inhibited
adhesion of BMMs from arthritic animals in relation to
BMMs from controls by trend 20 days p. i. and signifi-
cantly 40 days p. i. (Fig. 4a, c). Adhesion to laminin was
inhibited 40 days p. i. by trend (Fig. 4e). Analysis of add-
itional neurotransmitter effects on adhesion to ECM mole-
cules revealed no significant effects for ACh and 10−8 MNA (Fig. 4b, d, f). 10−6 M NA stimulation of BMMs isolated
from CIA rats 20 days p. i. showed reduced adhesion to fi-
bronectin (P= 0.0625, Fig. 4d) and laminin (P= 0.0625,
Fig. 4f). In control BMMs isolated 40 days after NaCl treat-
ment, 10−6 M NA led to significantly reduced adhesion to
collagen type I (Fig. 4b) and laminin (Fig. 4f) in relation to
non-stimulated cultures.
By trend, 10−9 M VIP inhibited adhesion to collagen type
I 20 days after NaCl treatment (P = 0.0625, Fig. 4b) and to
laminin 40 days after NaCl treatment (P = 0.0625, Fig. 4f).
Furthermore, we wanted to unravel the underlying mo-
lecular reason for the adhesion defect and therefore we an-
alyzed BMM expression of integrins CD29 (integrin β1)
and CD51/CD61 (integrin ανβ3)—which critically me-
diate these cell-matrix interactions—by flow cytometry
(Fig. 4g, h). We confirmed expression of CD29 on BMMs
(Fig. 4g) but did not detect differences in the percentage
Fig. 3 Adhesion of pre-cultured BMMs to plastic surface. Adhesion to plastic surface was measured 36 h after seeding, and pre-cultured BMMs
from controls and from CIA animals were compared (a). Data are shown as percentage of BMMs from control animals set to 100 %. Influence
of stimulation with ACh and VIP on adhesion of BMMs from control and CIA animals is shown as percentage to non-stimulated macrophages
(non-stimulated = dotted line) (b), and respective results for noradrenergic stimulation are shown under (c). N = 6 for control and CIA BMMs and
the applied neurotransmitters at each time point. Data are expressed as mean ± standard error of the mean. *P < 0.05 neurotransmitter stimulation
versus non-stimulated cells; ##P < 0.01 control cells versus CIA cells. ACh acetylcholine, BMM bone marrow-derived macrophage, CIA collagen
II-induced arthritis, NA noradrenaline, VIP vasoactive intestinal peptide
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BMMs (Fig. 4h). Integrin CD51/CD61 was not detectable
by fluorescence-activated cell sorting (data not shown).
Caspase 3/7 activity remains unaffected in collagen
II-induced arthritis
Changes in apoptotic activity could also explain the re-
duced number of CIA BMMs (Fig. 5). (For more detailed
data, see Additional file 4: Table S2E.)
However, apoptosis remained unaltered when com-
paring control BMMs with CIA BMMs. At day 40,
apoptosis of macrophages from arthritic animals was
enhanced but did not reach significance (Fig. 5a).
The effects of neurotransmitter stimulation were analyzed
by setting the non-stimulated cultures of control and CIA
BMMs as 100 % (Fig. 5b and c, dotted line) and calculating
the percentage of the respective neurotransmitter effects on
caspase 3/7 activity in control and CIA BMMs.
In control BMMs, α- (10−8 M) and β- (10−6 M) AR
stimulation with NA enhanced apoptosis at day 15 com-
pared with non-stimulated macrophages (Fig. 5c). NA
stimulation exerted opposite effects in controls and CIA
macrophages, as apoptosis was significantly lower in CIAcells compared with stimulated control BMMs 15 days p.
i. (Fig. 5c). 10−6 M ACh (P = 0.0938) and 10−9 M VIP by
trend enhanced apoptosis on day 15 in control BMMs
(Fig. 5b). Notably, stimulation of CIA macrophages with 10
−9 M VIP and 10−6 M ACh resulted in decreased apoptosis
rate at day 15 p. i. in relation to stimulated control BMM
cultures (Fig. 5b). After 20 days, VIP effects instead de-
creased apoptosis rate in controls (Fig. 5b).
Macrophage proliferation is strongly reduced in collagen
II-induced arthritis
Another aspect which might contribute to lower macro-
phage numbers from CIA rats is impaired proliferation
(Fig. 6 and Additional file 4: Table S2F).
When comparing proliferative capacity of macro-
phages from controls with CIA macrophages, a reduc-
tion of proliferation in CIA BMMs became noticeable
from day 10 p.i. (p=0,0906) and reached significance on
days 15 and 40 p.i. (Fig. 6a).
To further dissect the influence of CIA on prolifera-
tion, we analyzed the cell cycle distribution of BMMs
from control and arthritic animals in the course of
CIA. There were no apparent changes in cell cycle
Fig. 4 (See legend on next page.)
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Fig. 4 Adhesion of pre-cultured BMMs to extracellular matrix components and expression of integrin CD29. Adhesion to extracellular matrix
components collagen type I (a, b), fibronectin (c, d), and laminin (e, f) was measured 36 h after seeding, and cultured BMMs from controls and
from CIA animals (a, c, e) 20 and 40 days post immunization were compared. Data are shown as percentage of BMMs from control animals set
to 100 %. Influence of stimulation with ACh, VIP, and NA on extracellular matrix adhesion of BMMs from control and CIA animals is shown as
percentage to non-stimulated macrophages (100 % = solid line). Results for collagen type I are shown under (b), for fibronectin under (d), and
respective results for laminin are shown under (f). *P < 0.05 neurotransmitter stimulation versus non-stimulated cells; ##P < 0.01 control cells versus
CIA cells. g, h BMMs were analyzed by flow cytometry after 2 days of pre-culture. BMMs were positive for CD29 (integrin β1, g). h compares
expression levels of CD29 on BMMs from control and arthritic animals 20 and 40 days post immunization. N = 6 for control and CIA at each
time point. Boxplots show box with median and interquartile range and whiskers from minimum to maximum. ACh acetylcholine, BMM bone
marrow-derived macrophage, CIA collagen II-induced arthritis, NA noradrenaline, VIP vasoactive intestinal peptide
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(Additional file 5: Figure S3A-D).
The effects of neurotransmitter stimulation were ana-
lyzed by setting the non-stimulated cultures of control
and CIA BMMs as 100 % (Fig. 6b and c, dotted line) and
calculating the percentage of the respective neurotrans-
mitter effects on BrdU incorporation in control and CIA
BMMs.
Stimulation of control macrophages with 10−6 M ACh
and 10−9 M VIP resulted in a significant increase on dayFig. 5 Caspase 3/7 apoptosis assay of pre-cultured BMMs. Pre-cultured BMM
were incubated with caspase 3/7 reagent for 6–10 h. Percentage of apopto
under (a). Influence of ACh and VIP on apoptosis induction in BMMs from
percentage to non-stimulated macrophages (non-stimulated = dotted line)
under (c). N (control/CIA) = day 10 (9/10), day 15 (12/9), day 20 (10/10), and
(6/6), day 15 (6/3), day 20 (6/6), and day 40 (8/8) for ACh, VIP, and NA (10−6
*P < 0.05 neurotransmitter stimulation versus non-stimulated macrophages
marrow-derived macrophage, CIA collagen II-induced arthritis, NA noradren20 and a significant decrease in proliferation compared
with non-stimulated BMMs on day 40 (Fig. 6b). In CIA
BMMs, 10−6 M ACh reduced proliferation on day 40 p. i.
relative to non-stimulated CIA macrophages. On day 20,
ACh and VIP stimulation showed adverse effects between
control and CIA macrophages (Fig. 6b), including in-
creased proliferation in control BMMs and reduced prolif-
eration in CIA BMMs.
Stimulation with 10−8 M and 10−6 M NA reduced
proliferation of control macrophages in relation to non-s from control and CIA animals which were serum-deprived for 24 h
sis of CIA BMMs compared with BMMs from controls is presented
control and CIA rats during the time course of arthritis is shown as
(b). The respective results for noradrenergic stimulation are shown
day 40 (11/12). Neurotransmitter stimulation N (control/CIA) = day 10
M, 10−8 M). Data are expressed as mean ± standard error of the mean.
; #P < 0.05 control cells versus CIA cells. ACh acetylcholine, BMM bone
aline, VIP vasoactive intestinal peptide
Fig. 6 BrdU proliferation assay of pre-cultured BMMs. Pre-cultured BMMs from control and CIA animals which were serum-deprived for 24 h were cultured
in the presence of BrdU for 48 h. Percentage of cell proliferation of BMMs from CIA compared with control animals is depicted in (a). Influence of ACh and
VIP on proliferation of BMMs from control and CIA rats is shown as percentage to non-stimulated macrophages (non-stimulated = dotted line) (b).
Respective results for noradrenergic stimulation are shown under (c). N (control/CIA) = day 10 (11/12), day 15 (12/12), day 20 (12/12), and day 40
(14/14). Neurotransmitter stimulation N (control/CIA) = day 10 (6/6), day 15 (6/6), day 20 (8/8), and day 40 (8/8) for ACh, VIP, and NA (10−6 M, 10−8 M).
Data are expressed as mean ± standard error of the mean. *P < 0.05; **P < 0.01 neurotransmitter stimulation versus non-stimulated cells #P < 0.05;
##P < 0.01; ###P < 0.001 controls versus CIA. ACh acetylcholine, BMM bone marrow-derived macrophage, BrdU 5-bromo-2′-deoxyuridine, CIA
collagen II-induced arthritis, NA noradrenaline, VIP vasoactive intestinal peptide
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phages, stimulation with 10−6 M NA resulted in lower
proliferative capacity compared with non-stimulated
cells 40 days p. i. (Fig. 6c).
Discussion
Key players in RA inflammatory reactions are macro-
phages derived from myeloid precursors in the bone
marrow. Here, we wanted to analyze how the different
CIA stages affect metabolic features like adhesion, apop-
tosis, and proliferation of BMMs and how changes in
local neurotransmitter composition may add to meta-
bolic alterations of macrophages from arthritic animals.
The present in vitro study allowed us to dissect the neu-
rotransmitter influence from in vivo effects like co-
transmitter signaling and high levels of pro-inflammatory
cytokines (i.e. TNF and IL-1β).
To study macrophage characteristics, cells were enriched
from whole bone marrow preparations by their ability to
attach to untreated plastic surfaces [16]. Comparing the
different stages of CIA, we observed a noticeable decline
in macrophage numbers after 2 days of pre-culture onplastic surfaces from bone marrow isolated at the acute
disease stage with high-grade joint inflammation. To eluci-
date whether reduced monocyte/macrophage numbers in
the native bone marrow are the underlying cause, we ana-
lyzed the proportion of CD11b-positive and EMR1-
positive (rat homolog to murine F4/80) cells in controls
and animals with acute CIA. Strikingly, both markers were
significantly elevated in the bone marrow cell suspension
of rats with acute arthritis. Consistently, although Nishida
et al. [26] found markedly reduced total bone marrow cell
numbers in a murine CIA model which is similar to pa-
tients with RA [27], the proportion of cells from the mye-
loid lineage was found to be elevated in murine arthritis
models [6, 28]. The unsettled question remained, what has
caused the profound loss of macrophage numbers from
acutely arthritic animals after the 2-day enrichment phase
on plastic culture dishes?
Contributing to this observation might be the fact that
in our in vitro system we observed a strong reduction in
adherence of macrophages to plastic surfaces at the acute
arthritis stage, which might cause the lower BMM and
precursor cell numbers. Changes in plastic adherence have
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lupus erythematosus and RA, but results could have been
influenced by corticosteroid treatment [29]. We show that
in the CIA rat model this effect is independent of treat-
ment and therefore may represent a metabolic alteration
caused solely by inflammation.
In addition to observing this CIA effect, we observed
clear alterations in plastic adhesion in the presence of
NA, ACh, and VIP. By qualitative analysis of gene ex-
pression, we ensured that BMMs express a high range of
receptors for NA, ACh, and VIP. Immunostaining of se-
lected receptors showed no qualitative differences in
receptor expression by CIA or control BMMs, and the
expression of various receptors for specific neurotrans-
mitters might result in integrative effects for each of the
neurotransmitters. In case of adhesion to plastic, NA ef-
fects were stronger in BMMs isolated from NaCl-treated
control rats, with dose-dependent reduction of adhesion
(10−6 M) 15 days after NaCl treatment and enhancement
(10−8 M) after 40 days. This timely and possibly age-
dependent effect of NA influence on plastic adhesion
was also observed by Ortega et al. using peritoneal mac-
rophages [30]. We further report an influence of ACh
and VIP on plastic adhesion of BMMs from CIA rats,
which has not been investigated before. At disease onset,
ACh inhibited adhesion whereas in acute and chronic
stages VIP effects became more effective and strongly in-
creased plastic adhesion of CIA BMMs. Although there
are no direct data available for macrophages, Reardon
et al. found a decreased expression of adhesion mole-
cules on endothelial cells after ACh stimulation, inhibit-
ing neutrophil recruitment to inflammatory regions [31].
This effect was dependent on muscarinic receptors. In
line with our data, de la Fuente et al. observed that
stimulation of peritoneal macrophages with 10−9 M VIP
clearly enhanced adhesion [32]. A more detailed analysis
of BMM adhesion to specific components of ECM
would allow conclusions involving in vivo mechanisms
as macrophages migrate via anchorage to these macro-
molecules. Therefore, attachment studies on collagen
type I, fibronectin, and laminin were conducted. Studies
with peripheral blood monocytes [33] and synovial fibro-
blasts [34] derived from patients with RA revealed in-
creased integrin expression and enhanced attachment to
ECM molecules. However, we observed a noticeable re-
duction in adhesion to type I collagen and fibronectin at
the chronic disease state. Data for the acute arthritis
time-point did not reach significance possibly due to
small sample sizes. Attachment to laminin was inhibited
by CIA by trend in the chronic phase. In contrast to
plastic adherence, adhesion to collagen I and laminin
was inhibited in control BMMs in the presence of 10
−6 M NA 40 days after NaCl treatment. In BMMs de-
rived from rats with acute CIA, 10−6 M NA insteadreduced adhesion to fibronectin and laminin. 10−9 M
VIP tended to reduce adhesion of control BMMs to col-
lagen type I and laminin 20 and 40 days after NaCl treat-
ment, respectively. ACh and 10−8 M NA failed to induce
changes in adhesion to any of the analyzed macromole-
cules (collagen I, laminin, or fibronectin). Altogether, we
found an intrinsic defect in adhesion to plastic, collagen
I, and fibronectin and partly to laminin that was caused
by CIA and, in regard to macromolecules of the ECM,
would provide a handicap to enter sites of inflammation.
NA effects observed under physiological conditions are
dampened in arthritis. ACh and VIP influences on plas-
tic adherence emerge only under arthritic conditions,
and VIP effects on adhesion to laminin and collagen
type I affect only BMMs from healthy rats, indicating a
changing neurotransmitter response concerning adhe-
sion processes to different substrates caused by un-
known, CIA-associated mechanisms.
Concomitant flow cytometry studies of CD29 (integrin
β1) expression revealed no differences for BMMs from
arthritic rats. The activation status of CD29 was not dis-
tinguishable with the applied antibody; hence, we do not
know whether CIA induced higher activity or abolished
any activated state. CD51/CD61 (integrin ανβ3), another
integrin involved in ECM adhesion, was not detectable
in our culture set-up.
A major observation of this study included changes in
BMM proliferative capacity which occurred as early as
10 days p. i. (by trend) and persisted until the chronic
state with surprisingly little differences at the acute arth-
ritis stage. Implicating the decreased adhesion of CIA
BMMs at day 20 p. i., we presume a higher macrophage
proliferative capacity at the acute arthritis stage. En-
hanced proliferation in acute inflammatory reactions re-
flects a strong requirement for immune cells to resolve
inflammation, and a local proliferative burst has been
described for macrophages under acute inflammatory
conditions [35]. On the other hand, RA profoundly im-
pairs proliferative capacity of CD34+ hematopoietic ma-
crophage progenitor cells by inducing early immuno-
senescence in the HSC compartment [36]. A reduced
proliferative responsiveness to mitotic stimulation has
also been reported for spleen cells and peripheral blood
monocytes isolated from rats with adjuvant-induced
arthritis as early as 4 days after induction [37]. Impaired
proliferation reduces the HSC pool, but high levels of local
and systemic pro-inflammatory and pro-proliferative fac-
tors at the acute arthritis stage may overcome this mech-
anism and may lead to exhaustion of precursor pools in
chronic conditions. 10−6 and 10−8 M NA strongly de-
creased proliferation in control BMMs 40 days after NaCl
treatment, but only 10−6 M affected CIA BMMs with a
lower effect size. Similarly, as shown for cell culture as-
says, high- and low-dose NA—acting via β- and α-ARs,
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trast, stimulation with VIP and ACh enhanced proliferation
in BMMs from controls, whereas the effect was abrogated
in CIA cells at the acute arthritis time point. At the chronic
time point, ACh and VIP blocked proliferation of BMMs
from both controls and arthritic animals. ACh and VIP ef-
fects have been demonstrated to be predominantly anti-
inflammatory [39, 40] and this is in line with our data. The
anti-inflammatory effects of ACh have been ascribed mainly
to signaling through the α7 receptor subunit of the nicotinic
ACh receptor (“cholinergic anti-inflammatory reflex”) [41].
Surprisingly, we failed to detect gene and protein expression
for α7 nAChR and therefore cannot assign observed ACh
effects to that specific receptor. Instead, we detected mus-
carinic M1, M3, and M5 receptor mRNA, receptor subtypes
sharing the same signaling cascade [42]. M5 receptor agon-
ism induced a pro-proliferative response in cell culture ex-
periments using transfected NIH3T3 cells [24]. Interestingly,
a human melanoma cell line, A2058, displayed reduced clo-
nogenic potential using a novel signaling pathway via M5 re-
ceptor stimulation [25] and this might explain the opposite
ACh effects in acute and chronic CIA. VIP stimulation was
shown to inhibit proliferation of HSC progenitor cells
throughVIP receptor 1 [43].
Low-dose NA, also expected to be caused by retraction
of TH-positive nerve fibres in vivo [10], did not suppress
proliferation in CIA BMMs. Possibly, ACh and VIP com-
pensate for this CIA effect in the chronic arthritis stage.
In contrast to proliferation, insufficient apoptosis of
macrophages, which may be one of the underlying causes
for longtime disease persistence, seems to be locally re-
stricted to the synovial tissue [44] as the results of the
present study show no apparent changes in BMM apop-
tosis. Notably, for caspase 3/7-mediated apoptosis, we ob-
served opposite effects of NA with profound induction of
apoptosis in BMMs from controls and protection in CIA.
This was also true for ACh and VIP. These data implicate
that, at onset, CIA, via unknown mechanisms, preferably
protects BMMs from neurotransmitter-induced apoptosis.
In cell culture assays, NA effects mediated via β- and
α-ARs, respectively, would dose-dependently induce apop-
tosis in lymphocytes and a macrophage cell line [45, 46].
VIP effects were opposite but corroborate the contrary
observations in CIA and control BMMs: VIP strongly en-
hanced apoptotic caspase 3/7 activity in neutrophils from
healthy volunteers [47] but was also shown to rescue mur-
ine acinar cells from TNF-induced apoptosis [48]. Instead,
M3 and M5 muscarinic ACh receptors have neuroprotec-
tive effects by preventing apoptosis [49].
A striking observation made in this study was the fact that
not only BMMs from CIA rats showed differential reactivity
to neurotransmitter stimulation over time, related to differ-
ent disease stages, but also BMMs derived from controls.
Although we did not analyze this phenomenon more indepth, we suspect aging effects to be the underlying cause,
as this has been shown for NA effects on plastic adhesion of
peritoneal macrophages by Ortega et al. [30].
Conclusions
Here, we provide strong evidence that collagen-induced
arthritis alters intrinsic metabolic capacities of macro-
phages isolated from rat bone marrow and their reac-
tivity to neurotransmitter stimulation with NA, ACh,
and VIP. Starting early after immunization, CIA initiates
mechanisms that lead to impaired proliferative activity
exclusively at low and non-inflammatory stages. Highly
inflammatory conditions may override the underlying ef-
fects and restore or even enhance proliferation. Anti-
proliferative effects of low-dose NA were abrogated in
chronic arthritis, but altered reactivity to ACh and VIP
compensated for this effect and instead reduced BMM
proliferation, emphasizing the anti-inflammatory effects
of these neurotransmitters.
Pro-inflammatory conditions instead cause a strongly re-
duced plastic adhesion of macrophages evoking alterations
in in vivo-generated macrophage numbers. Additionally,
defective adhesion to type I collagen and fibronectin was
observed in chronic arthritis and might represent an actual
mechanism to hinder adhesion to ECM and to prevent
new inflammatory processes in the joints of rats with
chronic arthritis. Noradrenergic inhibition of adhesion to
collagen type I and laminin was effective only in BMMs
from healthy rats. An anergic state of CIA BMMs toward
NA-mediated inhibition of adhesion to ECM macromole-
cules would, in opposition to observed CIA effects, pro-
mote stronger infiltration.
From that we can conclude that BMMs are differentially
affected in their metabolic activity depending on disease
stage and the associated inflammatory status. Clearly, all
neurotransmitters investigated had strong adverse effects
in control and CIA macrophages, but modulation oc-
curred in a time- and assay-dependent manner. We sug-
gest that collagen-induced arthritis causes an altered
reactivity to neurotransmitter stimulation which has com-
pensatory functions in BMMs.
Additional files
Additional file 1: Table S1. Primer sequences for endpoint polymerase
chain reaction (PCR). bp base pairs.
Additional file 2: Figure S1. Collagen type II-induced arthritis (CIA).
Successful CIA induction was verified by monitoring body weight (a) and
arthritis score (b) of arthritic and control animals 10 (n = 40), 15 (n = 30),
20 (n = 20), and 40 (n = 10) days post immunization. Data are expressed
as mean ± standard error of the mean. **P < 0.01, ***P < 0.001.
Additional file 3: Figure S2. Endpoint polymerase chain reaction for
neurotransmitter receptors. Gene expression of neurotransmitter receptors
for ACh, NA, and VIP was analyzed by endpoint polymerase chain reaction
by using RNA isolated from BMM of controls 10 days (a) and 20 days (b)
Muschter et al. Arthritis Research & Therapy  (2015) 17:169 Page 14 of 15following sodium chloride treatment. N = 1. AR adrenoceptors, BMM bone
marrow-derived macrophage, bp base pairs, M1-M5 muscarinic acetylcholine
receptor, NA noradrenaline, nAChR nicotinic acetylcholine receptor, PACAPR1
pituitary adenylate cyclase-activating peptide receptor 1, VIPR1-2 vasoactive
intestinal peptide receptors 1 and 2.
Additional file 4: Table S2. Data summary for adhesion, apoptosis, and
proliferation assay. Table S2 summarizes data for adhesion assay (a-d), caspase
3/7 assay (e), and proliferation assay (f). Non-stimulated CIA data are shown as
percentage to BMM from control (100 %). Effects of neurotransmitter
stimulation are presented as percentage to the respective non-stimulated
CIA and control BMM (100 %). Data are expressed as mean ± standard error
of the mean. *P < 0.05 neurotransmitter stimulation versus non-stimulated
cells; #P < 0.05; ##P < 0.01; ###P < 0.001 control cells versus CIA cells. ACh
acetylcholine, BMM bone marrow-derived macrophage, CIA collagen
II-induced arthritis, NA noradrenaline, VIP vasoactive intestinal peptide.
Additional file 5: Figure S3. Cell cycle analysis. G0/G1 phase BMMs
from control and CIA rats were cultured in the presence of fetal calf
serum and macrophage colony-stimulating factor for 48 h and cell cycle
distribution was analyzed by measurement of nucleic propidium iodide
content. The graph compares the frequency of BMMs from control and
CIA animals distributed in cell cycle phases G0/G1, S, and G2/M. Results
for 10 days p. i. are presented under (a), 15 days p. i. under (b), 20 days p. i.
under (c) and 40 days p. i. under (d). N = 6 for control and CIA at each time
point. BMM bone marrow-derived macrophage, CIA collagen II-induced
arthritis, p. i. post-immunization.
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